Drug yields high response rates for lung cancer patients with harsh mutation

(University of Texas M. D. Anderson Cancer Center) A targeted therapy resurrected by the Moon Shots Program™ at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant mutation.